Holen Sie sich die Stockscreener-App
4.08
7.48%
-0.33
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt AVXL?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$4.41
Offen:
$4.36
24-Stunden-Volumen:
1.61M
Relative Volume:
0.71
Marktkapitalisierung:
$364.54M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-48.17M
KGV:
-7.1579
EPS:
-0.57
Netto-Cashflow:
$-37.10M
1W Leistung:
-10.72%
1M Leistung:
-37.13%
6M Leistung:
-49.75%
1J Leistung:
-51.31%
1-Tages-Spanne:
$3.96
$4.40
1-Wochen-Bereich:
$3.96
$4.88
52-Wochen-Spanne:
$2.86
$14.44
Anavex Life Sciences Corporation Stock (AVXL) Company Profile
Firmenname
Anavex Life Sciences Corporation
Sektor
Branche
Telefon
844-689-3939
Adresse
630 5TH AVENUE, NEW YORK
Vergleichen Sie AVXL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVXL
Anavex Life Sciences Corporation
|
4.08 | 394.03M | 0 | -48.17M | -37.10M | -0.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Anavex Life Sciences Corporation Stock (AVXL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-12-06 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-23 | Eingeleitet | Berenberg | Buy |
| 2021-09-23 | Eingeleitet | BTIG Research | Buy |
| 2020-12-16 | Bestätigt | H.C. Wainwright | Buy |
| 2020-09-28 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2020-02-27 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-06-18 | Eingeleitet | Janney | Buy |
| 2018-05-16 | Fortgesetzt | Maxim Group | Buy |
| 2018-03-08 | Eingeleitet | ROTH Capital | Buy |
| 2018-02-13 | Bestätigt | Maxim Group | Buy |
| 2017-09-29 | Fortgesetzt | Noble Financial | Buy |
| 2017-02-07 | Eingeleitet | Noble Financial | Buy |
| 2016-03-29 | Eingeleitet | FBR Capital | Outperform |
Alle ansehen
Anavex Life Sciences Corporation Aktie (AVXL) Neueste Nachrichten
How does Anavex Life Sciences Corporation (AVXL) change from a tortoise to a hare? - Setenews
Is Anavex Life Sciences Corp. stock a defensive play in 2025Market Risk Analysis & Growth Focused Stock Reports - Newser
AVXL Investors Have Opportunity to Join Anavex Life Sciences Corp. Fraud Investigation with the Schall Law Firm - The AI Journal
AVXL Investors Have Opportunity to Join Anavex Life Sciences Corp. Fraud Investigation with the Schall Law Firm - Benzinga
Down 50.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Anavex Life Sciences (AVXL) - Finviz
Can Anavex Life Sciences Corp. (12X1) stock sustain institutional flowsMarket Risk Summary & Technical Buy Zone Confirmations - Newser
Check Out Anavex Life Sciences Corporation (AVXL)’s Trade Data Rather Than the Analysts’ Views - Setenews
What analysts say about Anavex Life Sciences Corp stockEarnings Miss Alerts & Superior Capital Trading - earlytimes.in
Why Anavex Life Sciences Corp. stock could rally in 2025July 2025 Sector Moves & Low Risk High Reward Ideas - BỘ NỘI VỤ
D. Boral Capital Reaffirms Buy Rating for Anavex Life Sciences (NASDAQ:AVXL) - Defense World
Anavex Life Sciences’ (AVXL) Buy Rating Reiterated at D. Boral Capital - Defense World
Anavex Life Sciences (NASDAQ:AVXL) Earns “Buy” Rating from D. Boral Capital - Defense World
D. Boral Capital Reiterates Buy Rating for Anavex Life Sciences (NASDAQ:AVXL) - Defense World
Anavex Life Sciences (NASDAQ:AVXL) Given Buy Rating at D. Boral Capital - Defense World
D. Boral Capital Reaffirms "Buy" Rating for Anavex Life Sciences (NASDAQ:AVXL) - MarketBeat
Anavex Life Sciences And 2 Other Promising Penny Stocks To Watch - Yahoo Finance
Anavex (NASDAQ: AVXL) to present blarcamesine Phase IIb/III Alzheimer’s results at CTAD - Stock Titan
Anavex Life Sciences (NASDAQ:AVXL) Posts Earnings Results, Beats Expectations By $0.02 EPS - MarketBeat
Anavex Life Sciences Corp (AVXL) Q4 2025 Earnings Call Highlights: Strong Cash Position and ... - Yahoo Finance
Anavex Life Sciences Corp. Reports Earnings Results for the Fourth Quarter and Full Year Ended September 30, 2025 - MarketScreener
Anavex Life Sciences Reports Fiscal 2025 Fourth Quarter Financial Results and Provides Business Update - MarketScreener
Anavex Life Sciences (NASDAQ: AVXL) Quarter 2025 Reports $102.6M, Three-Year Runway - Stock Titan
You might want to take a look at Anavex Life Sciences Corporation (AVXL) now - Setenews
Will Anavex Life Sciences Corp. stock rally after Fed decisions2025 Breakouts & Breakdowns & Free Long-Term Investment Growth Plans - newser.com
Can Anavex Life Sciences Corp. stock maintain operating marginsWeekly Trade Review & Detailed Earnings Play Alerts - newser.com
How Anavex Life Sciences Corp. (12X1) stock trades after rate cuts - newser.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp.AVXL - cnhinews.com
Anavex Life Sciences Corp. to Release Fiscal Year End Financial Results on November 25, 2025 - Quiver Quantitative
Anavex Life Sciences to Announce Fiscal 2025 Fourth Quarter Financial Results on Tuesday, November 25, 2025 - marketscreener.com
Anavex Life Sciences (Nasdaq: AVXL) to Report Fiscal 2025 Results on Nov. 25 - Stock Titan
A significant driver of top-line growth: Anavex Life Sciences Corporation (AVXL) - Setenews
Can Anavex Life Sciences Corp. stock deliver strong Q4 earnings2025 Volatility Report & Real-Time Buy Zone Alerts - newser.com
Is Anavex Life Sciences Corp. stock resilient to inflationWeekly Investment Recap & Entry Point Confirmation Alerts - newser.com
Will Anavex Life Sciences Corp. (12X1) stock rise with strong economyJuly 2025 Opening Moves & Pattern Based Trade Signal System - newser.com
Anavex Life Sciences Shares Plummet Following EU Regulatory Setback - StocksToTrade
Anavex Life Sciences Stock Plummets Amid Regulatory Hurdles - StocksToTrade
How strong is Anavex Life Sciences Corp. stock revenue growthQuarterly Trade Review & Consistent Income Trade Ideas - newser.com
Will Anavex Life Sciences Corp. (12X1) stock deliver compounding returns2025 Dividend Review & Technical Entry and Exit Alerts - newser.com
D. Boral Capital Maintains Anavex Life Sciences (AVXL) Buy Recommendation - Nasdaq
Can Anavex Life Sciences Corp. stock attract ESG capital inflowsM&A Rumor & Growth Oriented Trade Recommendations - newser.com
Anavex Life Sciences Corp. (AVXL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Anavex Life Sciences (NASDAQ:AVXL) Reaches New 12-Month LowHere's Why - MarketBeat
Real time breakdown of Anavex Life Sciences Corp. stock performance2025 Macro Impact & Step-by-Step Trade Execution Guides - newser.com
Micron Tech, Netflix among market cap stock movers on Friday By Investing.com - Investing.com UK
Micron Tech, Netflix among market cap stock movers on Friday - Investing.com
Anavex shares collapse after CHMP issues negative signal on Alzheimer’s therapy - MSN
Anavex Life Sciences Corp. Provides Regulatory Update on Blarcamesine for Early Alzheimer's Disease - MarketScreener
Anavex Life Sciences Falls in Premarket Trading After Alzheimer's Drug Receives EU Regulatory Setback - MarketScreener
Anavex Faces CHMP Setback for Alzheimer’s Drug - MSN
Anavex Life Sciences Plans Re-examination Request Following CHMP Feedback and FDA Meeting on Alzheimer's Disease Trial Results - Quiver Quantitative
Anavex (NASDAQ: AVXL) to seek CHMP re-exam; formal opinion expected in December - Stock Titan
Finanzdaten der Anavex Life Sciences Corporation-Aktie (AVXL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):